Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hepion Pharmaceuticals (HEPA)
NASDAQ:HEPA
Holding HEPA?
Track your performance easily
HEPA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.48 - $3.72
Previous Close$0.49
Volume48.09K
Average Volume (3M)43.95K
Market Cap
$3.68M
Enterprise Value$4.41M
Total Cash (Recent Filing)$1.50M
Total Debt (Recent Filing)$2.22M
Price to Earnings (P/E)―
Beta2.48
Next Earnings
May 15, 2018EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.39
Shares Outstanding6,958,371
10 Day Avg. Volume55,851
30 Day Avg. Volume43,945
Standard Deviation0.29
R-Squared0.09
Alpha-0.07
Financial Highlights & Ratios
Price to Book (P/B)-2.72
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.18
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Hepion Pharmaceuticals News
PremiumCompany Announcements
Hepion Pharmaceuticals Terminates Merger with Pharma Two B
Ownership Overview
0.27%
Insiders
1.88% Mutual Funds
3.33% Other Institutional Investors
93.81% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
HEPA FAQ
What was Hepion Pharmaceuticals’s price range in the past 12 months?
Hepion Pharmaceuticals lowest stock price was $0.48 and its highest was $3.72 in the past 12 months.
What is Hepion Pharmaceuticals’s market cap?
Currently, no data Available
When is Hepion Pharmaceuticals’s upcoming earnings report date?
Hepion Pharmaceuticals’s upcoming earnings report date is May 15, 2018 which is 2413 days ago.
How were Hepion Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is Hepion Pharmaceuticals overvalued?
According to Wall Street analysts Hepion Pharmaceuticals’s price is currently Overvalued.
Does Hepion Pharmaceuticals pay dividends?
Hepion Pharmaceuticals does not currently pay dividends.
What is Hepion Pharmaceuticals’s EPS estimate?
Hepion Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hepion Pharmaceuticals have?
Hepion Pharmaceuticals has 6,958,371 shares outstanding.
What happened to Hepion Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Hepion Pharmaceuticals?
Currently, no hedge funds are holding shares in HEPA
---
Hepion Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-83.27%
12-Months-Change
Fundamentals
Return on Equity
-288.27%
Trailing 12-Months
Asset Growth
-85.14%
Trailing 12-Months
Company Description
Hepion Pharmaceuticals
Hepion Pharmaceuticals, Inc. engages in the development and commercialization of pleiotropic drug therapy for the treatment of chronic liver disease. It focuses on the development of its product candidate CRV431, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Edison, NJ.
---
HEPA Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Achieve Life Sciences
―
180 Life Sciences
―
Can-Fite BioPharma
―
Cyclerion Therapeutics
―
---